论文部分内容阅读
目的探讨新生儿呼吸衰竭患者运用新型鼻塞持续气道正压通气(NCPAP)治疗的临床效果。方法选择2012年2月—2014年2月诊治的172例呼吸衰竭新生儿,对患儿实施综合治疗后,随机分为两组,观察组的90例患儿实施新型鼻塞持续气道正压通气治疗,对照组82例进行简易水封瓶气道正压通气技术治疗,比较两组患儿治疗前后的血气监测结果、临床疗效。结果观察组90例患儿总有效率为84.4%;对照组为53.7%,差异有统计学意义(P<0.05)。与治疗前比较,经过治疗后,PaO2、SaO2、PaCO2、pH值均有改善,优于对照组,差异有统计学意义(P<0.05)。结论新生儿呼吸衰竭运用新型鼻塞持续起到正压通气治疗时一种有效、安全的辅助通气方式,值得在临床上推广使用。
Objective To investigate the clinical effect of nasal continuous positive airway pressure (NCPAP) treatment in neonatal respiratory failure patients. Methods A total of 172 newborn infants with respiratory failure who were diagnosed and treated from February 2012 to February 2014 were selected and randomly divided into two groups. Ninety children in the observation group underwent nasobiliary continuous positive airway pressure In the control group, 82 cases were treated with simple water-sealed bottle airway pressure ventilation. The blood gas monitoring results before and after treatment in both groups were compared, and the clinical curative effect was compared. Results The total effective rate was 84.4% in 90 cases of observation group and 53.7% in control group, the difference was statistically significant (P <0.05). Compared with before treatment, after treatment, PaO2, SaO2, PaCO2, pH values were improved, better than the control group, the difference was statistically significant (P <0.05). Conclusion Neonatal respiratory failure using a new type of nasal obstruction continues to play an effective and safe way of assisted ventilation when positive pressure ventilation is worthy of clinical promotion.